TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.

Michael G Ison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.